Trial information
A randomised trial of NT-proBNP guided patient management in heart failure clinics - A study in the Danish Network of Heart Failure Clinics
Status: Recruiting
Protocol number: P04M101
Sponsor: Roche Diagnostics
Company division: Diagnostic
Brief summary: This study will evaluate assessment of NT-proBNP levels before discharge on management and clinical outcomes in patients admitted with heart failure, and evaluate the use of NT-proBNP measurement in managing the patients followed in a heart failure clinic.
Study type: Interventional study
Condition: Heart Failure
Intervention type: Diagnostic Test
Intervention name: Elecsys®proBNP, Cardiac reader®proBNP
Inclusion criteria:
- Adult patients ≥18 years of age;
- Clinical stable heart failure, NYHA I-III.
Exclusion criteria:
- Candidates for surgical interventions;
- Severe renal dysfunction.
Gender: Males or Females
Accepts healthy volunteers: No
Anticipated start date: August, 2005
Trial registration date: 08/22/2005
Date last updated: 11/21/2008
Link to trial result
This trial is being conducted at the following locations:
Denmark